3/30/2024 | 30029010 | ANTI-CHIKUNGUNYA VIRUS IMMUNOGLOBULIN G 1 VIAL/UNIT (0.5ML/VIAL)(QTY:2 NOS)(0.005KG)(M NO:1502/19)ASPER INV | PAUL-EHRLICH-INSTITUT | 0.01 | KGS | 276.63 | GERMANY | HYDERABAD AIR |
3/30/2024 | 30029010 | 2,508 Vials of Noninfectious Human Plasma(2508 vials)(samplefoc) | LABCORP,INC. | 2508 | NOS | 15.18 | USA | HYDERABAD AIR |
3/30/2024 | 30029010 | CHIKUNGUNYA-VIRUS RNA 1 VIAL/UNIT (0.5ML/VIAL)(QTY:2 NOS)(0.005KG)(M NO:11785/16)ASPER INV | PAUL-EHRLICH-INSTITUT | 0.01 | KGS | 276.63 | GERMANY | HYDERABAD AIR |
3/29/2024 | 30029010 | HUMAN SERUM (FOR R&D PURPOSE ONLY) (FOC) | M/S. DIRECT HELPERS RESEARCH CENTER | 30 | NOS | 20.23 | USA | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 2ML X 139 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. LABCORP DEVELOPMENT (ASIA) PTE | 139 | NOS | 3.23 | SINGAPORE | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 2ML X 6 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. LABCORP DEVELOPMENT (ASIA) PTE | 6 | NOS | 0.13 | SINGAPORE | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 2ML X 28 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. LABCORP DEVELOPMENT (ASIA) PTE | 28 | NOS | 0.65 | SINGAPORE | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 2ML X 167 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. LABCORP DEVELOPMENT (ASIA) PTE | 167 | NOS | 3.88 | SINGAPORE | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 2ML X 8 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. LABCORP DEVELOPMENT (ASIA) PTE | 8 | NOS | 0.16 | SINGAPORE | BANGALORE AIR |
3/28/2024 | 30029010 | HUMAN SERUM 4ML X 1 VIALS (FOR R&D PURPOSE ONLY) (FOC) | M/S. ICON LABORATORIES | 1 | NOS | 10.12 | USA | BANGALORE AIR |